Acute and chronic ethanol exposure increases the risk of infection by altering the innate host's defense system. Adolescence is a critical period for brain development. Insults during this period may have long-lasting consequences. The present study investigated the effects of binge-like ethanol exposure in adolescent rats on mechanical hyperalgesia during sickness syndrome that was induced by a systemic injection of lipopolysaccharide (LPS) or an intracerebroventricular (i.c.v.) injection of interleukin-1β (IL-1β) after the cessation of ethanol exposure. Male Wistar rats were exposed to ethanol from postnatal day (PND) 25 to PND 38 in a binge-like pattern. Hyperalgesia was assessed on the right hindpaw after an intraperitoneal injection of LPS (5 and 50 μg/kg, intraperitoneally) on PND 51 and PND 63 or an i.c.v. or intraplantar (i.pl.) injection of IL-β (3 and 1 ng, respectively) on PND 51. Ethanol exposure during adolescence did not alter mechanical thresholds which increased normally with age. The systemic injection of LPS (0.5-50 μg/kg) in adult rats induced dose-related mechanical hyperalgesia. Binge-like ethanol exposure significantly increased mechanical hyperalgesia that was induced by 50 μg/kg LPS on PND 51 and 63, which lasted until 24 h after the injection. This change was not observed at a lower dose of LPS (5 μg/kg). Acute oral treatment with ethanol 24 h prior to LPS administration did not alter mechanical hyperalgesia. The i.c.v. injection of IL-1β (1-10 ng) also induced dose-related mechanical hyperalgesia in the right hindpaw in non-exposed animals. In animals that were exposed to binge-like ethanol, the i.c.v. or i.pl. injection of IL-1β also increased hyperalgesia on PND 51. These results suggest that binge-like ethanol exposure during adolescence causes alterations in the central nervous system that can increase mechanical hyperalgesia that is observed during sickness syndrome, and this effect can be observed until adulthood after the cessation of ethanol exposure.
Introduction
Ethanol (EtOH) consumption usually begins in early adolescence (12-14 years old) and increases until 21 years of age (Masten et al., 2009) . These individuals usually drink intermittently, frequently adopting a pattern of binge drinking (Masten et al., 2009 ). Binge drinking is a pattern of drinking that results in blood alcohol levels of 0.08 g/dl which is achieved approximately after five drinks for men and four drinks for women within a period of 2 h (NIAAA, 2016) . The World Health Organization has a similar definition for heavy episodic drinking, which is the consumption of 60 g or more of pure EtOH (six or more standard drinks in most countries) on at least one single occasion at least monthly (World Health Organization, 2014) . The consumption may reach 6.2 l of EtOH annually per person aged 15 years or older (World Health Organization, 2014) .
Adolescence is a critical period of life when complex interactions between genetic factors and environmental experiences remodel certain brain areas that confer neural growth into adulthood (Fine and Sung, 2014) . Excessive EtOH consumption during this period leads to changes in the prefrontal cortex, cerebellum, and hippocampus, followed by cognitive dysfunction and emotional and memory deficits (Fowler et al., 2014; Oliveira et al., 2015; Pascual et al., 2007; Pascual et al., 2014) .
In addition to these changes in the central nervous system, EtOH consumption can alter innate and adaptive immune responses (Goral et al., 2008; Jimenez-Ortega et al., 2011) . The pattern of EtOH ingestion is determining factor with regard to whether these changes are temporary or permanent. For example, Jimenez-Ortega et al. (2011) showed that intermittent EtOH consumption decreased lymph node and spleen lymphocyte cell populations more than acute or chronic EtOH consumption. The release of proinflammatory cytokines was shown to be suppressed after stimulation with lipopolysaccharide (LPS) and phytohemagglutinin in the blood after acute EtOH exposure in humans (Afshar et al., 2015) . Conversely, microglial activation and an increase in the synthesis of proinflammatory cytokines, chemokines, and tolllike receptors (TLRs) through nuclear factor ΚB activation is seen in the human, rat, and mouse brain during EtOH addiction (Crews et al., 2011) . Furthermore, intermittent EtOH exposure during adolescence induces inflammatory brain damage, characterized by higher levels of cyclooxygenase-2, nitric oxide synthase, and caspase 3 activity and apoptotic cell death, assessed by the determination of DNA fragments. This damage was associated with behavioral changes, such as worse performance on a conditional discrimination task, worse motor performance, lower discrimination of novel and familiar objects, and worse performance on a beam walking task (Pascual et al., 2007) . The higher levels of inflammatory markers in the central nervous system that are associated with behavioral changes in animals suggest that EtOH consumption influences pain processing.
Despite the habitual use of EtOH by patients with chronic pain, recent studies showed that intermittent EtOH consumption did not alleviate thermal hyperalgesia that was associated with neuropathic pain (Gonzalez-Sepulveda et al., 2016) . In fact, chronic EtOH administration induced tolerance to the antinociceptive effects of EtOH, and a hyperalgesic response was observed in the animals' paws 12 h after the last EtOH administration (Gatch, 2002) . Other studies reported that binge EtOH drinking induced mechanical, thermal, and inflammatory hyperalgesia during the withdrawal period (Bergeson et al., 2016; Dina et al., 2006) . The consumption of EtOH was shown to be a comorbid risk factor for peripheral neuropathy in patients who were treated for human immunodeficiency virus (Ferrari and Levine, 2010; Lopez et al., 2004; Moyle and Sadler, 1998; Nath et al., 2002) We recently found that binge exposure to EtOH during adolescence reduced the febrile response that was induced by LPS and interleukin-1β (IL-1β), even 12 days after the cessation of EtOH consumption (Telles et al., 2017) . The intraperitoneal (i.p.) administration of LPS caused a systemic inflammatory response syndrome that was characterized by fever, hyperalgesia, anorexia, and sleepiness. Altogether, these symptoms are referred to as sickness syndrome. The aim of the present study was to investigate whether binge-like EtOH administration during adolescence in rats affects LPS-and IL-1β-induced hyperalgesia during the sickness syndrome.
Materials and methods

Animals
The experiments were conducted in 21-day old (n = 108) and 60-day-old (n = 68) male Wistar rats that were obtained from the animal facility of the Federal University of Paraná. The animals were housed five per cage in a temperature-controlled room at 22°C ± 1°C under a 12 h/12 h light/dark cycle (lights on at 7:00 AM) with food and water available ad libitum. All of the procedures were conducted in accordance with the ethical guidelines of the International Association for the Study of Pain (Zimmermann, 1983) and Brazilian regulations on animal welfare. All of the procedures were previously approved by the institution's Ethical Committee for Animal Use and were in accordance with Brazilian and EU Directive 2010/63/EU Guidelines for Animal Care. All efforts were made to minimize the number of animals used and their suffering and the animals received only one injection of LPS or IL-1β.
Mechanical hyperalgesia
Mechanical hyperalgesia was assessed using an electronic Von Frey anaesthesiometer (Insight, Ribeirão Preto, SP, Brazil) as described previously (Redivo et al., 2016) . The animals were individually placed in a Plexiglas compartment (20 cm length × 25 cm width × 15 cm height) on a wire mesh floor platform for 60 min for habituation. The mesh floor allowed the tip of the anaesthesiometer to stimulate the midplantar right region of the hindpaw using a disposable polypropylene tip (0.5 mm diameter) that was connected to a force transducer and digital display that allowed determination of the force (in grams) applied. A linear increase in force was applied to the paw until the occurrence of a paw withdrawal response. The mechanical threshold was calculated as the average value of three similar withdrawal responses. The occurrence of mechanical hyperalgesia was determined as the difference between the average mechanical threshold observed prior to and at different time points after the administration of LPS or IL-1β.
Intracerebral cannula implantation and microinjection
For intracerebroventricular (i.c.v.) administration, a 22-gauge stainless-steel guide cannula (0.8 mm outer diameter, 12 mm length) was stereotaxically implanted in the right lateral ventricle under ketamine/xylazine (90/10 mg/kg) anesthesia on postnatal day 45 (PND 45). The stereotaxic coordinates were the following: 0.8 mm lateral to midline, 1.5 mm posterior to bregma, and 2.5 mm below the brain surface, with the incisor bar lowered 3.3 mm below horizontal zero (Paxinos and Watson, 1998) . The cannulas were fixed to the skull with jeweler's screws that were embedded in dental acrylic cement. The animals were allowed to recover for 5 days before the oral administration of EtOH on PND 50, followed by the injection of IL-1β on PND 51. After the end of the experiment, each rat was microinjected with Evans blue (2.5% in saline) in the lateral ventricle. The brains were removed, and animals that had cannula misplacements, cannula blockage during the injection, or abnormal body weight gain patterns after surgery were excluded from the study (2 animals in 56). IL-1β was administered over 1 min using polyethylene-10 PE-10 tubing.
Dose-response curve of LPS-and IL-1β-induced mechanical hyperalgesia
Basal mechanical thresholds in non-EtOH-exposed adult animals were measured as described above. After this measurement, the animals received 0.5, 5, and 50 μg/kg LPS, i.p. (E. coli, 0111:B4, Sigma-Aldrich, St. Louis, MO, USA). Hyperalgesia was evaluated every hour up to 6 h. Control animals received the same volume of vehicle (sterile saline). Basal mechanical thresholds were similarly measured in animals that received IL-1β (1, 3, and 10 ng/2 μl, i.c.v., R & D Systems, Minneapolis, MN, USA), and mechanical hyperalgesia was measured 3, 6, and 24 h after the injection.
2.5. Effect of EtOH exposure on mechanical hyperalgesia 2.5.1. Binge-like EtOH exposure during adolescence Ethanol (3 g/kg, 25% w/v in saline) was administered i.p. on PND 25 (EtOH-pretreated group). The control group received an equivalent volume of saline. On PND 26, 29, 30, 33, 34, 37 , and 38, the animals received the same treatment. This binge-like pattern was chosen based on Lerma-Cabrera et al. (2013) and Forbes et al. (2013) to simulate a pattern of acute intoxication (i.e., binge) that is common during adolescence in humans. The i.p. route of administration was chosen to avoid variations in blood EtOH levels that can be caused by different patterns of consumption of drinking water or inconsistent gastrointestinal absorption. To evaluate hyperalgesia, the animals were divided into two groups. In one group, 12 days after binge-like EtOH exposure (PND 50), the animals received an additional dose of EtOH or distilled water orally (Fig. 1 ). In the other group, 24 days after bingelike EtOH exposure (PND 62), the animals received an additional dose of EtOH or distilled water orally (Fig. 1) . The mechanical hyperalgesia experiments were performed the next day (PND 51 [ Fig. 1A ] or PND 63 [ Fig. 1B] ) when the animals were treated with saline, LPS (5 and 50 μg/ kg, i.p.), or IL-1β (3 pg/2 μl, i.c.v.). For comparison and to verify the effects of EtOH exposure on peripherally induced hyperalgesia, we also injected IL-1β (1 ng/100 μl) directly in the paw in saline-and EtOHexposed animals.
Effects of acute EtOH on mechanical hyperalgesia
In a separate group of animals, non-EtOH-exposed rats received a single dose of 3 g/kg EtOH (25% w/v in saline, p.o.) or an equivalent volume of saline (control group) 24 h before LPS administration. The next day, the animals received LPS (5 or 50 μg/kg, i.p.) or saline, and mechanical hyperalgesia was evaluated.
Data analysis
Mechanical hyperalgesia is presented as the intensity of hyperalgesia, which was calculated as a change in mechanical threshold before and after the injection of the stimulus. Mechanical hyperalgesia was analyzed by two-way repeated-measures analysis of variance (ANOVA) followed by the Bonferroni's test for multiple comparisons. The results are also presented as areas under the curve (AUCs; in arbitrary units [AU] ) of the intensity of hyperalgesia to reveal dose-response relationships and the total change in hyperalgesia. The AUCs were analyzed by one-way ANOVA followed by Bonferroni's test. Values of p < 0.05 were considered statistically significant. The data were analyzed using Prism 6 software (GraphPad, San Diego, CA, USA). Fig. 2 shows basal mechanical thresholds on PND 25, 51, and 63. The two-way ANOVA revealed a significant effect of time (F 2,42 = 58.45, p < 0.0001) but no significant differences were found between animals that received EtOH or saline during adolescence (F 1,21 = 0.2375, p > 0.05) on PND 51 or 63. No time × treatment interaction was observed (F 2,42 = 0.9468, p > 0.05).
Results
Mechanical thresholds at different ages
Mechanical hyperalgesia induced by LPS
The i.p. administration of LPS in naive animals induced a significant dose-dependent increase in hyperalgesia that began at 2 h and lasted for at least 6 h (Fig. 3A) . The two-way ANOVA revealed significant effects of time (F 6,120 = 275.3, p < 0.0001) and treatment (F 3,20 = 61.13, p < 0.0001) and a significant time × treatment interaction (F 18,120 = 31.67, p < 0.0001). Dose-response relationships were evaluated by calculating the AUCs from the data in Fig. 3A . The oneway ANOVA revealed a significant effect of treatment (F 3,20 = 59.33, p < 0.001; Fig. 3B ).
The 5 and 50 μg/kg doses were selected for further experiments in binge-like EtOH-exposed animals. The administration of 5 μg/kg LPS in EtOH-exposed animals induced hyperalgesia that was similar to salinetreated animals, which began 3 h after the injection and lasted until 2 . Effects of binge-like EtOH consumption on mechanical thresholds in rats at different ages. Mechanical thresholds were evaluated on PND 25, and then the animals were exposed to EtOH or saline (Sal) as described in Fig. 1 . Mechanical thresholds were assessed again on PND 51 and 63. The data are expressed as the mean ± SEM of mechanical thresholds (in grams; n = 7-17). *p < 0.05, compared with PND 25; # p < 0.05, compared with PND 51. Fig. 3 . Mechanical hyperalgesia induced by a systemic injection of LPS in non-EtOHexposed rats. Mechanical thresholds were assessed in adult rats prior to any experimental procedure (time 0). The animals received an i.p. injection of LPS (0.5, 5.0, or 50 μg/kg) or the same volume of saline (Sal). Mechanical thresholds were assessed again every hour up to 6 h. (A) The mean ± SEM of the intensity of hyperalgesia, which was calculated as the change in threshold (Δ threshold; in grams) before and after LPS administration (n = 6). B.M.T. de Oliveira et al. Pharmacology, Biochemistry and Behavior 160 (2017) 63-69 24 h on both PND 51 and 63 (data not shown). The two-way repeatedmeasures ANOVA revealed significant effects of time (F 3,129 = 395.8, p < 0.0001) and treatment (F 3,43 = 63.66, p < 0.0001) and a significant time × treatment interaction (F 9,129 = 55.64, p < 0.0001) on PND 51 and significant effects of time (F 3,57 = 98.12, p < 0.0001) and treatment (F 3,19 = 26.45, p < 0.0001) and a significant time × -treatment interaction (F 9,57 = 17.29, p < 0.0001) on PND 63. However, the administration of 50 μg/kg LPS induced a significantly higher hyperalgesic response in EtOH-exposed animals on both PND 51 and 63 ( Fig. 4A and B, respectively) . The two-way repeated-measures ANOVA revealed significant effects of time (F 3,114 = 448.2, p < 0.0001) and treatment (F 3,38 = 137.9, p < 0.0001) and a significant time × treatment interaction (F 9,114 = 95.41, p < 0.0001) on PND 51 and significant effects of time (F 3,66 = 89.85, p < 0.0001) and treatment (F 3,22 = 45.36, p < 0.0001) and a significant time × -treatment interaction (F 9,66 = 18.04, p < 0.0001) on PND 63. Fig. 4C shows the AUCs, emphasizing the differences between saline-and EtOH-exposed animals after LPS administration and the absence of differences between saline-and EtOH-exposed animals after saline administration. The one-way ANOVA revealed significant effects of treatment on PND 51 (F 3,38 = 139.7, p < 0.0001) and PND 63 (F 3,22 = 49.75, p < 0.0001).
To evaluate whether these differences between saline-and EtOHtreated animals were attributable to EtOH administration on the day before the LPS injection, we evaluated mechanical hyperalgesia in naive animals that received an acute injection of EtOH 24 h before LPS administration. The administration of 50 μg/kg LPS induced significant hyperalgesia in both EtOH-and saline-treated animals (F 3,14 = 88.94, p < 0.0001), with a significant effect of time (F 3,42 = 279.4, p < 0.0001; Fig. 5A ) and a significant time × treatment interaction (F 9,42 = 44.70, p < 0.0001). Ethanol-treated animals exhibited higher mechanical hyperalgesia only 3 h after the LPS injection compared with animals that received saline. At the other time points (6 and 24 h), no difference was observed between groups. The AUC analysis also indicated no difference between saline-and EtOH-treated animals that received LPS (Fig. 5B) , with a significant effect of treatment (F 3,4 = 88.49, p < 0.0001) for the animals that received LPS when compared to the respective saline group. B.M.T. de Oliveira et al. Pharmacology, Biochemistry and Behavior 160 (2017) 63-69 
Mechanical hyperalgesia induced by IL-1β
We then evaluated whether the differences in mechanical hyperalgesia between saline-and binge-like EtOH-exposed animals would also be observed after an injection of IL-1β, which is one of the most important mediators that is released after LPS administration. Additionally, to determine whether these differences were attributable to changes in the central nervous system after EtOH exposure, we chose to inject IL-1β i.c.v. The i.c.v. injection of IL-1β induced a dose-dependent increase in mechanical hyperalgesia (Fig. 6A) . The two-way ANOVA revealed significant effects of time (F 3,66 = 512.5, p < 0.0001) and treatment (F 3,22 = 135.1, p < 0.0001) and a significant time × treatment interaction (F 9,66 = 68.44, p < 0.0001). The AUC analysis revealed a dose-dependent response (F 3,22 = 123.1, p < 0.0001, Fig. 6B ). The i.c.v. administration of IL-1β also induced a significant increase in hyperalgesia in saline-and EtOH-treated animals, with significant effects of time (F 3,45 = 210.4, p < 0.0001) and treatment (F 3,15 = 126.1, p < 0.0001) and a significant time × -treatment interaction (F 9,45 = 52.53, p < 0.0001; Fig. 7A ). Mechanical hyperalgesia that was induced by i.c.v. IL-1β in EtOH-exposed animals was significantly higher at 6 and 24 h compared with salinetreated animals. This result was confirmed by the AUC analysis (Fig. 7C,  left panel) . The one-way ANOVA revealed a significant effect of treatment (F 3,15 = 111.9, p < 0.0001). Similar results were observed with the i.pl. injection of IL-1β, which also induced a significant increase in hyperalgesia in saline-and EtOH-treated animals, with significant effects of time (F 3,51 = 512.2, p < 0.0001) and treatment (F 3,17 = 300.2, p < 0.0001) and a significant time × treatment interaction (F 9,51 = 127.1, p < 0.0001; Fig. 7B ). Mechanical hyperalgesia that was induced by the i.pl. injection of IL-1β in EtOH-exposed animals was significantly higher at 3, 6, and 24 h compared with salinetreated animals. This result was confirmed by the AUC analysis (Fig. 6C,  right panel) . The one-way ANOVA revealed a significant effect of treatment (F 3,17 = 256.5, p < 0.0001).
Discussion
The main finding in the present study was that binge-like EtOH administration during adolescence increased mechanical hyperalgesia Mechanical hyperalgesia induced by an intracerebroventricular or intraplantar injection of IL-1β in naive and EtOH-exposed rats. IL-1β (3 ng) or saline (Sal) was injected (A) intracerebroventricularly or (B) in the paw on PND 51 after binge-like exposure to EtOH or Sal. Mechanical thresholds were evaluated 3, 6, and 24 h after the injection of IL-1β. The data are expressed as the mean ± SEM of the intensity of hyperalgesia, calculated as the change in threshold (Δ threshold; in grams) before and after IL-1β administration (n = 7-14). (C) The mean ± SEM areas under the curve (in arbitrary units [AU] ) that were calculated from the data in A (i.c.v.) and B (paw). *p < 0.05, compared with Sal-treated group; # p < 0.05, compared with respective Sal/IL-1β group.
that was induced by LPS and IL-1β. These effects were evident after EtOH withdrawal and persisted until adulthood. Ethanol exposure for long periods of time induces hyperalgesia. Dina et al. (2006) used different protocols and found that consecutive EtOH administration in rats, followed by periods of withdrawal, resulted in mechanical hyperalgesia that lasted at least 12 days after the last withdrawal. Similarly, Bergeson et al. (2016) showed that shortterm binge-like EtOH administration induced mechanical and cold hyperalgesia in mice and increased formalin-induced nociception. Mechanical and cold thresholds returned to baseline 2 and 3 days after the cessation of EtOH exposure in male and female mice, respectively. Both studies used adult animals, and the results suggested that EtOH exposure can cause hyperalgesia that affects pain that is induced by different stimuli (e.g., mechanical, thermal, and chemical).
In the present study, we found that mechanical thresholds increased with age. As expected, older animals presented higher mechanical thresholds. However, in contrast to previous studies, we did not detect differences in thresholds between saline-and EtOH-exposed animals at any age analyzed during the withdrawal period. The precise reason for this discrepancy is unknown. Importantly, EtOH exposure in the previous studies occurred in adult animals, which may be a critical factor in the development of hyperalgesia. This difference may also be related to the dose of EtOH or to the administration regimen. The protocol used may have induced a hyperalgesic response that lasted < 12 days, and therefore was not evaluated in the present study because we were interested in assessing later time points after withdrawal.
As mentioned previously, Bergeson et al. (2016) found that EtOH exposure potentiated formalin-induced nociception in mice. In the present study, we found that binge-like EtOH exposure during adolescence produced similar changes in mechanical hyperalgesia that was induced by LPS and IL-1β (i.e., increase in mechanical hyperalgesia on PND 51 and 63). Corroborating this previous study, we also found that the i.pl. injection of IL-1β in EtOH-exposed rats induced more intense hyperalgesia compared with animals that were exposed only to saline. However, in contrast to Bergeson et al. (2016) , we found that the i.c.v. injection of IL-1β increased hyperalgesia in EtOH-exposed animals. This result suggests that EtOH exposure in a binge-like pattern promotes changes in the central nervous system that contribute to this increase in pain sensitivity.
Previous studies showed that EtOH administration for 70 days lowered mechanical thresholds, which began 5 weeks after EtOH treatment and lasted for 20 days after withdrawal (Miyoshi et al., 2006; Narita et al., 2007c) . This regimen of chronic EtOH consumption activated microglia in the spinal cord, which persisted for 24 days after the cessation of EtOH consumption. In addition to microglial activation, hyperalgesia that is induced by chronic EtOH exposure appears to depend on the expression of the NR2B subunit of N-methyl-D-aspartate receptors and the dysfunction μ opioid receptors that are linked to conventional protein kinase C activation in the spinal cord (Narita et al., 2007a (Narita et al., , 2007b . Therefore, the binge-like protocol that was used in the present study might be sufficient to cause some of these changes that can contribute to the greater sensitivity to LPS.
Increases in microglial activation and changes in receptor expression may be related to the disruption of barrier function in the intestine because EtOH exposure also disrupts this barrier. Bacterial components can enter the circulation, and serum LPS levels increase in individuals with alcoholism, which can activate TLR4 (Szabo et al., 2007; Szabo and Lippai, 2014) . The presence of bacterial components in the circulation that is caused by EtOH-induced disruption of the intestinal barrier may be particularly important during adolescence because it can influence brain development and remodeling, thus altering not only addictive and affective disorders as suggested by Crews et al. (2011) but also pain sensations.
The amygdala is a central structure that may have been responsible for the hyperalgesic effects that were observed in the present study. The amygdala plays a well-known role in attaching emotional significance to sensory stimuli, including nociception (DeBerry et al., 2015; Watabe et al., 2013) . During chronic pain (e.g., arthritis), corticotrophin-releasing factor (CRF) and CRF 1 receptors contribute to pain-related sensitization in the amygdala (Ji and Neugebauer, 2007) . The CRF-CRF 1 system is also implicated in hyperalgesia in EtOH-dependent rats (Edwards et al., 2012) , and chronic ethanol administration leads to withdrawal-induced increases in brain CRF levels (Funk et al., 2006; Merlo Pich et al., 1995) . In rats that are exposed to the binge-like model of EtOH administration, CRF may act in the amygdala to modify or augment nociceptive responses.
The hyperalgesic changes that were observed in the present study and febrile response that was reported in a previous study (Telles et al., 2017) after exposure to EtOH were in opposite directions. Binge-like EtOH exposure intensified hyperalgesia, but it reduced the febrile response. Interestingly, the reduction of fever was observed only on PND 51 and was restored on PND 63, whereas the increase in hyperalgesia was observed on both PND 51 and 63. These results suggest that different mechanisms are involved in these phenomena. They also indicate that central mechanisms are involved in the effects of EtOH exposure because IL-1β was administered directly into the central nervous system. Therefore, although the changes in the febrile response lasted for some time but did not persist until adulthood, the hyperalgesic effects persisted for a longer period of time after the cessation of EtOH exposure and may persist until adulthood.
Importantly, in our previous study, we did not observe significant changes in hematological parameters or the number, viability, or functionality (i.e., IL-1β synthesis) of peritoneal macrophages (Telles et al., 2017) , suggesting that although the animals had lower body weight, they had overall normal health status. Previous studies observed changes in macrophages. Previous studies of the short-term effects of EtOH on macrophages reported both the activation and suppression of these cells (D'Souza et al., 2013; Muralidharan et al., 2014; Pascual et al., 2011) . Additionally, the opposite effects of binge-like EtOH on fever and hyperalgesia may counteract possible suppressive or stimulatory effects of EtOH on these cells, which may contribute to an explanation for our results.
These alterations in mechanical hyperalgesia may not be attributable to acute EtOH exposure because no changes were observed in rats that received EtOH the day before the LPS injection compared with rats that received saline. This result corroborates a previous study that reported that 1-day exposure to EtOH did not induce mechanical hyperalgesia the next day (Dina et al., 2006) .
In conclusion, the present study showed that binge-like EtOH exposure during adolescence produced changes in the central nervous system that increased sensitivity to a systemic noxious stimulus. These findings may have important implications with regard to quality of life after the cessation of EtOH exposure.
